willardiine has been researched along with cx 614 in 1 studies
Studies (willardiine) | Trials (willardiine) | Recent Studies (post-2010) (willardiine) | Studies (cx 614) | Trials (cx 614) | Recent Studies (post-2010) (cx 614) |
---|---|---|---|---|---|
43 | 0 | 10 | 30 | 0 | 15 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arai, AC; Kessler, M; Lynch, G; Rogers, G | 1 |
1 other study(ies) available for willardiine and cx 614
Article | Year |
---|---|
Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466.
Topics: Alanine; Animals; Anti-Anxiety Agents; Benzodiazepines; Benzothiadiazines; Cells, Cultured; Diuretics; Drug Interactions; Electrophysiology; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Hippocampus; Humans; In Vitro Techniques; Male; Oxazines; Pyrimidinones; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Recombinant Proteins; Sodium Chloride Symporter Inhibitors; Tritium; Uracil | 2000 |